During the past decade, JSI Research and Training Institute conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "JSI Research and Training Institute" are "HIV Infections" (3 trials). Many other conditions were trialed in "JSI Research and Training Institute" in a lesser frequency.

Most popular intervention types in "JSI Research and Training Institute" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Indinavir sulfate" (2 trials), "Stavudine" (2 trials), "Didanosine" (1 trials), "HIV-1 Immunogen" (1 trials) and "Lamivudine" (1 trials). Other intervention names were less common.

The vast majority of trials in "JSI Research and Training Institute" are 3 trials for "All" genders.

Currently, there are NaN active trials in "JSI Research and Training Institute". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in JSI Research and Training Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in JSI Research and Training Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".